INS and type 1 diabetes mellitus: Postmeal administration of insulin glulisine has been studied in patients with type 1 diabetes, and was shown to provide glycaemic control equivalent to that of premeal insulin glulisine and RHI, with a small but statistically significant body weight loss over 12 weeks [6].